missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MAPRE2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA553483
This item is not returnable.
View return policy
Description
Immunogen sequence: SSSGSASKSD KDLETQVIQL NEQVHSLKLA LEGVEKERDF YFGKLREIEL LCQEHGQEND DLVQ Highest antigen sequence identity to the following orthologs: Mouse - 98%, Rat - 98%.
The protein encoded by this gene shares significant homology to the adenomatous polyposis coli (APC) protein-binding EB1 gene family. The function of this protein is unknown; however, its homology suggests involvement in tumorigenesis of colorectal cancers and proliferative control of normal cells. This gene may belong to the intermediate/early gene family, involved in the signal transduction cascade downstream of the TCR. Alternative splicing results in multiple transcript variants.
Specifications
| MAPRE2 | |
| Polyclonal | |
| Unconjugated | |
| MAPRE2 | |
| AI314113; APC-binding protein EB1; APC-binding protein EB2; C820009F03Rik; CSCSC2; D18Abb1e; EB1; EB2; End-binding protein 2; Mapre2; microtubule associated protein RP/EB family member 2; microtubule-associated protein RP/EB family member 2; microtubule-associated protein, RP/EB family, member 2; RP1; T-cell activation protein, EB1 family; T-cell activation protein, EB1 family, member 2 | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 10982 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q15555 | |
| MAPRE2 | |
| Recombinant protein corresponding to Human MAPRE2. Recombinant protein control fragment (Product #RP-92427). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction